Graduate School of Life Sciences
Refine
Is part of the Bibliography
- yes (85)
Year of publication
- 2020 (85) (remove)
Document Type
- Doctoral Thesis (84)
- Journal article (1)
Keywords
- Aufmerksamkeit (3)
- Maus (3)
- T-Lymphozyt (3)
- Thrombozyt (3)
- Angststörung (2)
- Candida albicans (2)
- Einzelmolekülmikroskopie (2)
- Evolution (2)
- FKBP52 (2)
- Graft-versus-host-disease (2)
- Herzinsuffizienz (2)
- Immunologie (2)
- Neisseria meningitidis (2)
- Sozialangst (2)
- Spinale Muskelatrophie (2)
- Tissue Engineering (2)
- cytoskeleton (2)
- fMRI (2)
- platelet (2)
- social anxiety (2)
- tDCS (2)
- 2-point Dixon (1)
- 3D spheroid culture (1)
- A2B adenosine receptor (1)
- A2BAR (1)
- AMPK (1)
- ASM (1)
- ASM-Inhibition (1)
- Adenosinrezeptor (1)
- Adhesion and Invasion (1)
- Adhesion and degranulation promoting adapter protein (1)
- Adipose Tissue Engineering (1)
- Affekt (1)
- Aktive Implantate (1)
- Analgesie (1)
- Angst (1)
- Antigen presentation (1)
- Antigen recognition (1)
- Antigenpräsentation (1)
- Arrestine (1)
- Arteriosklerose (1)
- Arzneimitteldesign (1)
- Atmungsinsuffizienz (1)
- Augenbewegung (1)
- Autoimmunity (1)
- Autoimmunität (1)
- Autophagie (1)
- Autophagy (1)
- Aversive Konditionierung (1)
- BCG (1)
- BIN2 (1)
- BOLD signal (1)
- Bacteria (1)
- Bacteria-Host Cell Interaction (1)
- Bacteroides thetaiotaomicron (1)
- Bestrahlung (1)
- Biene (1)
- Bienen <Familie> (1)
- Bildartefakte (1)
- Biologische Uhr (1)
- Bioprozessmethode (1)
- Blinatumomab (1)
- Blumeria graminis (1)
- Blut-Nerven-Barriere (1)
- Bone Marrow Dosimetry (1)
- Bone Quantification (1)
- Bone morphogenetic protein 2 (1)
- Brain derived neurotorphic factor (1)
- Brustkrebs (1)
- Butyrophilin (1)
- CAMP production (1)
- CAR T Zellen (1)
- CAR T-cells (1)
- CD1d (1)
- CLEC16A (1)
- CRISPR/Cas-Methode (1)
- Calcium signalling (1)
- Calciumkanal (1)
- Carotis Intima Media Dicke (1)
- Cas9 (1)
- Cation Homeostasis (1)
- Caveolin-1 (1)
- Ceramid (1)
- Chemokine receptors (1)
- Citalopram (1)
- Clonal competition assay (1)
- Co-Analgetika (1)
- Coactosin-like (1)
- Commensalism (1)
- Complexome (1)
- Computational Fluid Dynamics (1)
- Computerunterstütztes Verfahren (1)
- Contrast Agent Bolus Based Perfusion Magnetic Resonance Imaging (1)
- Cul4b (1)
- Cuticle (1)
- DEQCT (1)
- DNA-Reparatur (1)
- DNS (1)
- DNS-Reparatur (1)
- Darm (1)
- Dasatinib (1)
- Dendritic cells (1)
- Dendritische Zelle (1)
- Dendritische Zellen (1)
- Depression (1)
- Diabetes mellitus Typ 1 (1)
- Diphenylether (1)
- Dispersal (1)
- Dolutegravir (1)
- Droseraceae (1)
- Drosophila (1)
- Drosophila melanogaster (1)
- E. coli Nissle (1)
- E1 inhibitoren (1)
- E1 inhibitors (1)
- EEG (1)
- Electroencephalographie (1)
- Elektroencephalographie (1)
- Emotionale Informationsverarbeitung (1)
- Endorganschaden (1)
- Endothel (1)
- Entscheidungsverhalten (1)
- Enzym (1)
- Epigenetik (1)
- Epithelzelle (1)
- Escherichia coli (1)
- Extinktion (1)
- Extracellular Matrix (1)
- FRET (1)
- FRET sensors (1)
- Fat Quantification (1)
- FemX (1)
- Fettgewebe (1)
- Fettsucht (1)
- Fettsäurestoffwechsel (1)
- Fettzelle (1)
- Fitness (1)
- Fluoreszenz (1)
- Fluoreszenz-Resonanz-Energie-Transfer (1)
- Fluoreszenzmikroskopie (1)
- Fluoreszenzspektroskopie (1)
- Frizzled 5 (1)
- Funktionelle Kernspintomografie (1)
- Funktionsausfälle (1)
- Furchtextinktion (1)
- Förster Resonance Energy Transfer (1)
- G protein-coupled receptor kinase (1)
- G protein-coupled receptors (1)
- G-Protein gekoppelte Rezeptoren (1)
- GPCR dimerisation (1)
- GPCR nanodomains (1)
- GPCR signaling (1)
- GPVI (1)
- GWAS (1)
- Gap Junction (1)
- Gefäßalter (1)
- Genetics (1)
- Genexpression (1)
- Genom (1)
- Genome Instability (1)
- Genomic Selection (1)
- Germination and differentiation (1)
- Glioblastomtherapie (1)
- Glycolipid (1)
- Grad-seq (1)
- Gram-positive bacteria (1)
- HIV (1)
- HIV Drug resistance (1)
- HIV South Africa (1)
- Heart failure (1)
- Heat shock protein 90 (1)
- Helikasen (1)
- Hemmung der Proliferation schnell wachsender Krebszellen (1)
- Herzhypertrophie (1)
- Herzschrittmacher (1)
- Hfq (1)
- Hi-C (1)
- High throughput screening (1)
- Hippokampus (1)
- Hirnstimulation (1)
- Histone (1)
- Hitzeschock-Proteine (1)
- Hitzeschockprotein 90 (1)
- Hochauflösende Mikroskopie (1)
- Homöostase (1)
- Honigbienen (1)
- Host Colonization (1)
- Hypertrophie (1)
- Hypothalamus (1)
- IL-12p70 (1)
- IMP1/ZBP1 (1)
- Ighmbp2 (1)
- Immunmodulation (1)
- Immunology (1)
- Immunophilin (1)
- Immuntherapie (1)
- Individual based model (IBM) (1)
- Informationsverarbeitung (1)
- Inhibition (1)
- Integrase inhibitor (1)
- Internal Dosimetry (1)
- Ionisierende Strahlung (1)
- Irradiation (1)
- K5 capsule (1)
- Kardiologie (1)
- Kationen-Homöostase (1)
- Kinase (1)
- Kinetik (1)
- Konditionierung (1)
- Kontextkonditionierung (1)
- Kontrastmittel-gestützte MRT-Perfusionsmessung (1)
- Kontrolle (1)
- Koronare Herzkrankheit (1)
- Krebs <Medizin> (1)
- LPS (1)
- Lactobacillus reuteri (1)
- Luftfeuchtigkeit (1)
- MDSCs (1)
- MLN7243 (1)
- MM (1)
- MRI (1)
- Magnetische Resonanz (1)
- Magnetresonanztomographie (1)
- Megakaryocyte (1)
- Methyltransferase (1)
- Microbiota (1)
- Microscopy (1)
- Mikroskopie (1)
- Molecular Radiotherapy (1)
- Molekularbiologie (1)
- Moosfaserterminalen (1)
- Motoneuronenerkrankung (1)
- Multiproteinkomplex (1)
- Myeloma (1)
- N-MYC (1)
- NNMT (1)
- NSM2 (1)
- Nanofabrication (1)
- Nanofabrikation (1)
- Naturschutz (1)
- Neisseria gonorrhoeae (1)
- Nerven (1)
- Nicht-kartesische Bildgebung (1)
- Nicotiana tabacum (1)
- Non-Hodgkin-Lymphom (1)
- Non-coding RNA (1)
- Non-conventional T cell (1)
- Nuclar Medicine (1)
- Numerische Fluidmechanik (1)
- Oligomerisation (1)
- Opiatrezeptor (1)
- Opioide (1)
- Panik (1)
- Panikstörung (1)
- Paniksyndrom (1)
- Parkinson-Krankheit (1)
- Pathogenicity (1)
- Peptides (1)
- Permeabilität (1)
- Peyer's patch (1)
- Pflanzen-Bienen-Netzwerke (1)
- PhD thesis pharmacology (1)
- Pharmakodynamik (1)
- Phosphatase (1)
- Phosphoantigen (1)
- Platelets (1)
- Powdery mildew fungus (1)
- Primärtumor (1)
- ProQ (1)
- Probiotic (1)
- Profilin (1)
- Prognose (1)
- Prädiktoren und Korrelate (1)
- Psychologie (1)
- Pulswelle (1)
- Quantitative Genetics (1)
- RNA (1)
- RNA helicase (1)
- RNA-binding protein (1)
- RNS (1)
- RNS-Bindungsproteine (1)
- Raf kinase inhibitor protein (1)
- RecQ helicase (1)
- Regulation of Gene Expression (1)
- Regulatorische T-Zellen (1)
- Regulatorischer T-Lymphozyt (1)
- Remission (1)
- Renaturierung <Ökologie> (1)
- Repeats (1)
- Rezeptorpharmakologie (1)
- Roscovitine (1)
- Rothmund-Thomson-Syndrome (1)
- SMARD1 (1)
- STD patients (1)
- Sandminen (1)
- Saure Sphingomyelinase (1)
- Schmerz (1)
- Secretion (1)
- Sequenzanalyse (1)
- Serotonin (1)
- Serotonin-Reuptake-Hemmer (1)
- Serotonin-Wiederaufnahmehemmer (1)
- Sertralin (1)
- Signalkette (1)
- Signaltransduktion (1)
- Small non-messenger RNS (1)
- Soziale Wahrnehmung (1)
- Spatial heterogeneity (1)
- Sphingolipide (1)
- Sphingolipidstoffwechsel (1)
- Sphingomyelin (1)
- Sphingomyelinphosphodiesterase (1)
- Spinal muscular atrophy (DLC) (1)
- Staphylococcus (1)
- Staphylococcus aureus (1)
- Stk (1)
- Stp (1)
- Streptococcus pneumoniae (1)
- Super-resolution microscopy (1)
- Super-resolution microsopy (1)
- Superhochauflösende Mikroskopie (1)
- T Zell Selektion (1)
- T cell activation (1)
- T cell selection (1)
- T zellen (1)
- TFIIH (1)
- TFIIIC (1)
- TP53 (1)
- TP53 lesions (1)
- TRPC (1)
- TRPC-Ionenkanäle (1)
- TRPC3 (1)
- TT-Fields (1)
- TTF (1)
- Tageslänge (1)
- Taufliege (1)
- Temporal heterogeneity (1)
- Theoretical Ecology (1)
- Therapie (1)
- Therapieoutcome (1)
- Thymosin b4 (1)
- Thymus (1)
- Toleranz (1)
- Transcription Factor (1)
- Transkriptionsfaktor (1)
- Transkriptomanalyse (1)
- Trypanosoma brucei brucei (1)
- Tumor Treating Fields (1)
- Tumortherapiefeld (1)
- Type II-C CRISPR/Cas (1)
- Type VIIb secretion system (1)
- USP (1)
- Ubiquitin (1)
- Ubiquitin activating eznyme 1 (1)
- Ubiquitin-Protein-Ligase (1)
- Ubiquitin-aktivierende Enzym 1 (1)
- Ubiquitinierung (1)
- VSG (1)
- Vaccine (1)
- Vagusnervstimulation (1)
- Vakzinen (1)
- Vaskuläre Integrität (1)
- Vermeidungsreaktion (1)
- Vermeidungsverhalten (1)
- Verweildauer (1)
- Vgamma9Vdelta2 T cell (1)
- Virtuelle Realität (1)
- Visuelle Aufmerksamkeit (1)
- WNT (1)
- Wachstumsfaktor (1)
- Wildbienen (1)
- Wirbelströme (1)
- Wnt-Proteine (1)
- X-ray crystallography (1)
- Xiphophorus Melanom (1)
- Zebrabärbling (1)
- Zellkern (1)
- Zellkernarchitektur (1)
- Zellmigration (1)
- Zellskelett (1)
- Zellwand (1)
- adipocytes (1)
- adipogenic differentiation (1)
- adipose (1)
- adipose-derived (1)
- antigenic variation (1)
- anxiety conditioning (1)
- artifizielle Hautmodelle (1)
- asialoGM1 (1)
- auditory cortex (1)
- autophagy (1)
- bacterial fatty-acid biosynthesis (1)
- bee microbiota (1)
- bee-associated bacteria (1)
- bestäuberfreundliche Pflanzen (1)
- biased agonism (1)
- biomedical applications (1)
- bioprocessing (1)
- bone regeneration (1)
- cadherin-13 (1)
- carnivorous plants (1)
- chlamydia trachomatis (1)
- chromosome conformation capture (1)
- circadian clock (1)
- circuitopathies (1)
- continuous wavelet analysis (1)
- control (1)
- current source density (1)
- decision-making (1)
- deubiquitinase (1)
- ectopic bone formation (1)
- ectopic release (1)
- emojis (1)
- emotional feedback (1)
- emotional information processing (1)
- emotionale Anspannung (1)
- enoyl-ACP reductase (1)
- exotische Pflanzen (1)
- extracellular signal–regulated kinases 1/2 (1)
- eye-tracking (1)
- fMRI time series (1)
- fear extinction (1)
- fear generalization (1)
- fgf (1)
- freezing of gait (1)
- funktionelle Kernspintomographie (1)
- gastrointestinal infection (1)
- gastronintestinal microbiota (1)
- genomics (1)
- hippocampus (1)
- histone variants (1)
- honey bees (1)
- honeybees (1)
- human induced pluripotent stem cells (1)
- humanen induzierte pluripotente Stammzellen (1)
- iNKT cell (1)
- in vivo study (1)
- induzierte Phosphatasen MKP-1 und MKP-2 (1)
- inferiore frontale Gyrus (1)
- inflammatorische Gewebeschäden (1)
- inhibitor residence time (1)
- insects (1)
- intestinal mucus (1)
- intracellular calcium release (1)
- ketamine anaesthesia (1)
- lambdoid phage resistance (1)
- laminar recording (1)
- learning and behaviour (1)
- lytic phage resistance (1)
- mTOR (1)
- megachilid bees (1)
- mesenchymal stem cells (1)
- mesoscopic (1)
- metabolic modelling (1)
- metabolism (1)
- metatranscriptome (1)
- microbial transmission (1)
- microbiota (1)
- microcircuitry (1)
- mitochondria (1)
- mossy fiber terminal (1)
- motoneuron (1)
- multi-modal stimuli (1)
- mutually exclusive expression (1)
- neurobiology (1)
- neuroblastoma (1)
- neurodevelopment (1)
- next generation sequencing (1)
- nitric oxide (1)
- nuclear architecture (1)
- oligomerization (1)
- opioid receptor (1)
- parasitology (1)
- phage resistance (1)
- photoinduced electron transfer (1)
- photoinduzierter Elektronentransfer (1)
- plant-bee visitation networks (1)
- pollen foraging (1)
- pollen metabarcoding (1)
- pollinator friendly plants (1)
- population dynamics (1)
- predictors and correlates (1)
- rIFG (1)
- reduction of ERK1/2 phosphorylation (1)
- reduction of cells proliferation (1)
- resting tremor (1)
- rtPA (1)
- sand mine (1)
- scale-up (1)
- secretory properties (1)
- serotonin (1)
- signalling (1)
- single molecule microscopy (1)
- single-molecule imaging (1)
- single-molecule microscopy (1)
- site directed immobilization (1)
- social attention (1)
- solitary bee nests (1)
- spatial organization (1)
- structure-based drug design (1)
- suspension culture (1)
- sustained fear (1)
- t cell (1)
- therapy of glioblastoma (1)
- therapy outcome (1)
- transcranial direct current stimulation (1)
- transcutaneous vagus nerve stimulation (1)
- transkranielle Gleichstromstimulation (1)
- translation (1)
- ubiquitin chain formation (1)
- ubiquitin linkage specificity (1)
- ubiquitin recognition (1)
- ultimatum game (1)
- variant surface glycoprotein (1)
- virtual reality (1)
- visual attention (1)
- vmPFC (1)
- wild bees (1)
Institute
- Graduate School of Life Sciences (85)
- Rudolf-Virchow-Zentrum (5)
- Fakultät für Biologie (4)
- Institut für Pharmakologie und Toxikologie (4)
- Institut für Psychologie (4)
- Medizinische Fakultät (4)
- Theodor-Boveri-Institut für Biowissenschaften (4)
- Institut für Virologie und Immunbiologie (3)
- Deutsches Zentrum für Herzinsuffizienz (DZHI) (2)
- Institut für Anatomie und Zellbiologie (2)
Sonstige beteiligte Institutionen
Ketamine is commonly used as an anaesthetic agent and has more recently gained attention as an antidepressant. It has been linked to increased stimulus‐locked excitability, inhibition of interneurons and modulation of intrinsic neuronal oscillations. However, the functional network mechanisms are still elusive. A better understanding of these anaesthetic network effects may improve upon previous interpretations of seminal studies conducted under anaesthesia and have widespread relevance for neuroscience with awake and anaesthetized subjects as well as in medicine. Here, we investigated the effects of anaesthetic doses of ketamine (15 mg kg\(^{-1}\) h\(^{-1}\)i.p.) on the network activity after pure‐tone stimulation within the auditory cortex of male Mongolian gerbils (Meriones unguiculatus). We used laminar current source density (CSD) analysis and subsequent layer‐specific continuous wavelet analysis to investigate spatiotemporal response dynamics on cortical columnar processing in awake and ketamine‐anaesthetized animals. We found thalamocortical input processing within granular layers III/IV to be significantly increased under ketamine. This layer‐dependent gain enhancement under ketamine was not due to changes in cross‐trial phase coherence but was rather attributed to a broadband increase in magnitude reflecting an increase in recurrent excitation. A time–frequency analysis was indicative of a prolonged period of stimulus‐induced excitation possibly due to a reduced coupling of excitation and inhibition in granular input circuits – in line with the common hypothesis of cortical disinhibition via suppression of GABAergic interneurons.
Neisseria meningitidis (N. meningitidis) is a human commensal that occasionally causes life-threatening infections such as bacterial meningitis and septicemia. Despite experi-mental evidence that the expression of small non-coding RNAs (sRNAs) as well as the RNA chaperone Hfq affect meningococcal physiology, the impact of RNA-based regula-tion (riboregulation) on fitness and virulence in N. meningitidis is only poorly understood. Therefore, this study addressed these issues using a combination of high-throughput tech-nologies.
A differential RNA-sequencing (dRNA-seq) approach was applied to produce a single-nucleotide resolution map of the primary transcriptome of N. meningitidis strain 8013. The dRNA-seq analysis predicted 1,625 transcriptional start sites including 65 putative sRNAs, of which 20 were further validated by northern blot analysis. By Hfq RNA im-munopreci-pitation sequencing a large Hfq-centered post-transcriptional regulatory net-work comprising 23 sRNAs and 401 potential mRNA targets was identified. Rifampicin stability assays demonstrated that Hfq binding confers enhanced stability on its associat-ed sRNAs. Based on these data, the interactions of two paralogous sRNAs and their cog-nate target mRNA prpB were validated in vivo as well as in vitro. Both sRNAs directly repress prpB encoding a methylisocitrate lyse which was previously shown to be involved in meningococcal colonization of the human nasopharynx.
Besides the well-described RNA chaperone Hfq, FinO-domain proteins have recently been recognized as a widespread family of RNA-binding proteins (RBPs) with regulatory roles in diverse bacteria. They display an intriguing bandwidth of target sites, ranging from a single RNA pair as recognized by plasmid-encoded FinO to the global RNA regu-lons of enterobacterial ProQ proteins. To better understand the intrinsic targeting mode of this RBP family, in vivo targets of the minimal ProQ protein of N. meningitidis were de-termined. In vivo UV crosslinking with RNA deep sequencing (UV-CLIP) identified as-sociations of ProQ with 16 sRNAs and 166 mRNAs encoding a variety of biological functions and thus revealed ProQ as another global RBP in meningococci. It could be shown that meningococcal ProQ predominantly binds to highly structured RNA regions including DNA uptake sequences (DUS) and rho-independent transcription terminators and stabilizes many of its RNA targets as proved by rifampicin stability experiments. As expected from the large suite of ProQ-bound RNAs, proQ deletion globally affects both gene and protein expression in N. meningitidis, changing the expression levels of at least 244 mRNAs and 80 proteins. Phenotypic analyses suggested that ProQ promotes oxida-tive stress tolerance and UV damage repair capacity, both of which are required for full virulence of N. meningitidis.
Together, this work uncovers the co-existence of two major post-transcriptional regulons, one governed by ProQ, the other by Hfq, in N. meningitidis. It further highlights the role of these distinct RBPs and its associated sRNAs to bacterial virulence and indicates that riboregulation is likely to contribute to the way how meningococci adapt to different host niches.
A continuous arms race between the development of novel antibiotics and the evolution of corresponding resistance mechanisms in bacteria has been observed, since antibiotic agents like arsphenamines (e.g. Salvarsan, developed by Paul Ehrlich [1]), sulphonamides (e.g. Prontosil, Gerhard Domagk [2]) and penicillin (Alexander Fleming [3]) were first applied to effectively cure bacterial infections in the early 20th century. The rapid emergence of resistances in contrast to the currently lagging discovery of antibiotics displays a severe threat to human health. Some serious infectious diseases, such as tuberculosis or melioidosis, which were either thought to be an issue only in Third-World countries in case of tuberculosis, or regionally restricted with respect to melioidosis, are now on the rise to expand to other areas. In contrast, methicillin-resistant Staphylococcus aureus (MRSA) is already present in clinical setups all over the world and causes severe infections in immunocompromised patients. Thus, there is an urgent need for new and effective antimicrobial agents, which impair vital functions of the pathogen’s metabolism.
One central metabolic pathway is represented by the bacterial fatty-acid synthesis pathway (FAS II), which is essential for the synthesis of long and branched-chain fatty acids, as well as mycolic acids. These substances play a major role as modulating components of the properties of the most important protective barrier – the cell envelope. The integrity of the bacterial cell wall and the associated membrane(s) is crucial for cell growth and for protection against physical strain, intrusion of antibiotic agents and regulation of uptake of ions and other small molecules. Thus, this central pathway represents a promising target for antibiotic action against pathogens to combat infectious diseases. The last and rate-limiting step is catalysed by the trans-2-enoyl-ACP reductase (ENR) FabI or InhA (in mycobacteria), which has been demonstrated to be a valuable target for drug design and can be addressed, amongst others, by diphenyl ether (DPE) compounds, derived from triclosan (TCL) – the first one of this class which was discovered to bind to ENR enzymes [4, 5].
Based on this scaffold, inhibitors containing different combinations of substituents at crucial positions, as well as a novel type of substituent at position five were investigated regarding their binding behaviour towards the Burkholderia pseudomallei and Mycobacterium tuberculosis ENR enzymes bpFabI and InhA, respectively, by structural, kinetic and in-vivo experiments. Generally, substitution patterns modulate the association and dissociation velocities of the different ENR inhibitors in the context of the two-step slow-onset binding mechanism, which is observed for both enzymes. These alterations in the rapidity of complex formation and decomposition have a crucial impact on the residence time of a compound and hence, on the pharmacokinetic properties of potential drug candidates. For example, the substituents at the 2’-position of the DPE scaffold influence the ground- and transition state stability during the binding process to bpFabI, whereas 4’-substituents primarily alter the transition state [6]. The novel triazole group attached to the 5-position of the scaffold, targeting the hydrophobic part of the substrate-binding pocket in InhA, significantly enhances the energy barrier of the transition state of inhibitor binding [7] and decelerates the association- as well as the dissociation processes. Combinations with different substituents at the 2’-position can enhance or diminish this effect, e.g. by ground-state stabilisation, which will result in an increased residence time of the respective inhibitor on InhA.
Further structural investigations carried out in this work, confirm the proposed binding mode of a customised saFabI inhibitor [8], carrying a pyridone moiety on the DPE scaffold to expand interactions with the protein environment. Structural and preliminary kinetic data confirm the binding of the same inhibitor to InhA in a related fashion. Comparisons with structures of the ENR inhibitor AFN-1252 [9] bound to ENR enzymes from other organisms, addressing a similar region as the pyridone-moiety of the DPE inhibitor, suggest that also the DPE inhibitor bears the potential to display binding to homologues of saFabI and InhA and may be optimised accordingly.
Both of the newly investigated substituents, the pyridone moiety at the 4’-position as well as the 5-triazole substituent, provide a good starting point to modify the DPE scaffold also towards improved kinetic properties against ENR enzymes other than the herein studied and combining both groups on the DPE scaffold may have beneficial effects. The understanding of the underlying binding mechanism is a crucial factor to promote the dedicated design of inhibitors with superior pharmacokinetic characteristics.
A second target for a structure-based drug-design approach is the interaction surface between ENR enzymes and the acyl-carrier protein (ACP), which delivers the growing acyl chain to each distinct enzyme of the dissociated FAS-II system and presumably recognises its respective interaction partner via electrostatic contacts. The interface between saACP and saFabI was investigated using different approaches including crosslinking experiments and the design of fusion constructs connecting the ACP and the FabI subunits via a flexible linker region of varying lengths and compositions. The crosslinking studies confirmed a set of residues to be part of the contact interface of a previously proposed complex model [10] and displayed high crosslinking efficiency of saACP to saFabI when mutated to cysteine residues. However, crystals of the complex obtained from either the single components, or of the fusion constructs usually displayed weak diffraction, which supports the assumption that complex formation is highly transient. To obtain ordered crystals for structural characterisation of the complex it is necessary to trap the complex in a fixed state, e.g. by a high-affinity substrate attached to ACP [11], which abolishes rapid complex dissociation. For this purpose, acyl-coupled long-residence time inhibitors might be a valuable tool to elucidate the detailed architecture of the ACP-FabI interface. This may provide a novel basis for the development of inhibitors that specifically target the FAS-II biosynthesis pathway.
The human body is colonized by trillions of microbes from all three domains of life – eukaryotes, bacteria and archaea. The lower gastrointestinal tract is the most densely colonized part of the body, harbouring a diverse and dynamic community of microbes. While the importance of bacteria in this so-called microbiota is well acknowledged, the role of commensal fungi remains underexplored. The most prominent fungus of the human gastrointestinal microbiota is Candida albicans. This fungus occasionally causes life-threatening disseminated infections in individuals with debilitated immune defences. It is this “pathogenic” facet that has received the most attention from researchers in the past, leaving many aspects of its “commensal” lifestyle understudied. Using gnotobiotic mice as a model system to explore the biology of C. albicans in the mammalian gut, in this dissertation I establish the global response of the host to C. albicans monocolonization as well as the spatial distribution of the fungus in the intestine in the context of co-colonization with single gut bacterial species. The fungus elicited transcriptome changes in murine intestinal tissue, which included the activation of a reactive oxygen species-related defence mechanism and the induction of regulators of the circadian clock circuitry. Both responses have previously been described in the context of a complete bacterial microbiota. Imaging the intestine of animals monocolonized with the fungus or co-colonized with C. albicans and the gut bacteria Bacteroides thetaiotaomicron or Lactobacillus reuteri revealed that the fungus was embedded in a B. thetaiotaomicron-promoted outer mucus layer in the murine colon. The gel-like outer mucus constitutes a unique microhabitat, distinct in microbial composition from the adjacent intestinal lumen. This finding indicates that bacteria can shape the specific microhabitat occupied by the fungus in the intestine. Overall, the results described in this dissertation suggest that gnotobiotic mice constitute a valuable tool to dissect multiple aspects of the interactions among host, commensal fungi and cohabiting bacteria.
Die nicht-invasive Gefäßdiagnostik stellt einen wichtigen Pfeiler in der Prävention von Herz-Kreislauferkrankungen dar. Während lange Zeit die sonographische Messung der cIMT, als morphologisches Korrelat der Gefäßalterung, als Goldstandard galt, ist in den letzten Jahren in Gestalt der Pulswellenanalyse/PWV-Messung eine Technik weiterentwickelt worden, die, als funktionelles Korrelat der Gefäßalterung, aufgrund der leichteren Durchführbarkeit und geringerer Untersucherabhängigkeit und Kosten vielversprechend ist. So erlaubt die Messung der Pulswelle mittels gewöhnlicher Blutdruckmanschetten, genau wie die cIMT, die Berechnung des individuellen Gefäßalters und die Diagnostik für das Vorliegen eines Endorganschadens der Blutgefäße.
Um die Messergebnisse der beiden Untersuchungen miteinander zu vergleichen, wurden beide in der EUROASPIRE-IV Studie an Patienten mit koronarer Herzkrankheit durchgeführt. Die Auswertung der Messergebnisse der mit dem Vascular Explorer durchgeführten Pulswellenanalyse/PWV-Messung ergab überraschenderweise, dass die Mehrheit der herzkranken Patienten weder eine vaskuläre Voralterung noch einen Endorganschaden der Blutgefäße aufweisen. Im Falle der cIMT-Messung war Gegenteiliges der Fall, was trotz der medikamentösen Therapie der Patienten so zu erwarten war. Weiterhin zeigte sich lediglich eine geringe Korrelation zwischen den Messergebnissen beider Untersuchungen. Die Determinanten der einzelnen Messwerte aus cIMT und Pulswellenanalyse/PWV-Messung waren deckungsgleich mit den in der Literatur beschriebenen Faktoren, wenn auch viele der sonst signifikanten Regressoren das Signifikanzniveau in unserer Auswertung nicht unterschritten.
Eine Limitation der funktionellen Gefäßdiagnostik liegt derzeit darin, dass die Messergebnisse stark von dem verwendeten Messgerät abhängen. Es liegen noch zu wenig Vergleichsstudien vor, um die Messergebnisse, speziell von neueren Geräten wie dem Vascular Explorer, auf andere zu übertragen. Bei der Berechnung des Gefäßalters sollten daher optimalerweise gerätespezifische Normwerte vorliegen, was beim Vascular Explorer nicht der Fall ist. Gleiches gilt für die Verwendung des PWVcf-Grenzwerts für die Diagnose eines Endorganschadens der Blutgefäße.
Analog hat auch die Messung der cIMT gewisse Einschränkungen. So wäre eine weitere Standardisierung der Messorte (A. carotis communis vs Bulbus vs A. carotis interna), zwischen denen sich die durchschnittliche cIMT erheblich unterscheidet, sowie der Messparameter (Minimal- vs Maximal- vs Mittelwert) wünschenswert. Die universelle Anwendung eines cIMT-Grenzwerts zur Diagnose eines Endorganschadens der Blutgefäße ist daher kritisch zu sehen. Dies zeigt sich auch darin, dass in den neuesten Leitlinien der bislang geltende Grenzwert angezweifelt und kein aktuell gültiger Grenzwert mehr genannt wird.
Wir interpretieren unsere Ergebnisse dahingehend, dass unsere Messung der cIMT die zu erwartende pathologische Gefäßalterung bei Patienten mit koronarer Herzkrankheit besser widerspiegelt als die Messung der Pulswelle mit dem Vascular Explorer. Welche der beiden Untersuchungen hinsichtlich der prognostischen Wertigkeit überlegen ist, muss im Rahmen von Längsschnittstudien geklärt werden.
Nicotinamide N-methyltransferase (NNMT) is a new regulator of energy homeostasis. Its expression is increased in models of obesity and diabetes. An enhanced NNMT level is also caused by an adipose tissue-specific knockout of glucose transporter type 4 (GLUT4) in mice, whereas the overexpression of this glucose transporter reduced the NNMT expression. Furthermore, the knockdown of the enzyme prevents mice from diet-induced obesity (DIO) and the recently developed small molecule inhibitors for NNMT reverses the DIO. These previous findings demonstrated the exclusive role of NNMT in adipose tissue and further make it to a promising target in obesity treatment. However, the regulation mechanism of this methyltransferase is not yet clarified.
The first part of the thesis focus on the investigation whether pro-inflammatory signals are responsible for the enhanced NNMT expression in obese adipose tissue because a hallmark of this tissue is a low-level chronic inflammation. Indeed, the NNMT mRNA in our study was elevated in obese patients compared with the control group, whereas the GLUT4 mRNA expression does not differ between lean and obese humans. To analyze whether pro inflammatory signals, like interleukin (IL 6) and tumor necrosis factor α (TNF-α), regulate NNMT expression 3T3-L1 adipocytes were treated with these cytokines. However, IL 6, TNF α, and leptin, which is an alternative activator of the JAK/STAT pathway, did not affect the NNMT protein or mRNA level in differentiated 3T3-L1 adipocytes. The mRNA and protein levels were measured by quantitative polymerase chain reaction (qPCR) and western blotting.
In the second part of this study, 3T3-L1 adipocytes were cultivated with varying glucose concentrations to show whether NNMT expression depends on glucose availability. Further studies with activators and inhibitors of AMP-activated protein kinase (AMPK) and mechanistic target of rapamycin (mTOR) signaling pathways were used to elucidate the regulation mechanism of the enzyme.
The glucose deprivation of differentiated 3T3-L1 adipocytes led to a 2-fold increase in NNMT expression. This effect was confirmed by the inhibition of the glucose transports with phloretin as well as the inhibition of glycolysis with 2-deoxyglucose (2-DG). AMPK serves as an intracellular energy sensor and the pharmacological activation of it enhanced the NNMT expression. This increase was also caused by the inhibition of mTOR. Conversely, the activation of mTOR using MHY1485 prevented the effect of glucose deprivation on NNMT. Furthermore, the NNMT up-regulation was also blocked by the different autophagy inhibitors.
Taken together, NNMT plays a critical role in autophagy in adipocytes, because an inhibition of this process prevented the augmented NNMT expression during glucose starvation. Moreover, the effect on NNMT protein and mRNA level depends on AMPK and mTOR. However, pro-inflammatory signals did not affect the expression. Further in vivo studies have to clarify whether AMPK activation and mTOR inhibition as well as autophagy are responsible for the increased NNMT levels in obese adipose tissue. In future this methyltransferase emerges as an awesome therapeutic target for obesity.
Divalent cations are important second messengers triggering various signal transduction events in platelets. Whereas calcium channel blockers have an established antithrombotic effect and the regulation of Ca2+ homeostasis has been elucidated in platelets, the molecular regulation of Mg2+ and Zn2+ homeostasis has not been investigated so far.
In the first part of the thesis, the role of -type serine-threonine kinase linked to transient receptor potential cation channel, subfamily M, member 7 (TRPM7) in platelets was investigated. Using Trpm7R/R mice with a point mutation deleting the kinase activity, we showed that the TRPM7 kinase regulates platelet activation via immunoreceptor tyrosine-based activation motif (ITAM), hem(ITAM) and protease-activated receptor (PAR) signaling routes. Furthermore, Trpm7R/R mice were protected from in vivo thrombosis and stroke, thus establishing TRPM7 kinase as a promising anti-thrombotic target.
In the second part of the thesis, the role of TRPM7 channel in a megakaryocyte (MK) and platelet-specific knockout mouse, Trpm7fl/fl-Pf4Cre, was investigated. Here, we observed that depending on the type of stimulation, Trpm7fl/fl-Pf4Cre platelets showed either enhanced or inhibited responses. Although Trpm7fl/fl-Pf4Cre mice were thrombocytopenic, no differences to wildtype mice were observed in models of in vivo thrombosis and stroke. The above two studies highlight that inhibition of TRPM7 kinase but not the channel itself (in MKs and platelets) may be a promising anti-thrombotic strategy.
Besides TRPM7, we investigated the role of magnesium transporter 1 (MAGT1) in platelet Mg2+ homeostasis and found that MAGT1 primarily regulates receptor-operated calcium entry (ROCE) in platelets specifically upon GPVI activation. This physiological crosstalk is triggered by protein kinase C (PKC) isoforms. Platelets from Magt1-/y mice hyper-reacted to GPVI and thromboxane A2 (TXA2) receptor stimulation in vitro. Consequently, Magt1-/y platelets were found to be pro-thrombotic in disease models of thrombosis and stroke.
To compare platelet ITAM-signaling to the immune system, we further investigated the role of MAGT1 in T and B cells. We described the primary role of MAGT1 in mice under pathogen-free conditions. Magt1-/y B cells showed dysregulated Mg2+ and Ca2+ homeostasis upon B-cell receptor activation, thereby altering Syk, LAT, phospholipase C (PLC)2 and PKC phosphorylation. In contrast to human MAGT1-deficient T cells, development and effector functions of mouse Magt1-/y T cells showed no alterations.
Finally, in the last part of the thesis, we described methods to measure intracellular free zinc [Zn2+]i in human and mouse platelets with storage pool disease (SPD). We propose to measure the [Zn2+]i status in SPD platelets as a relatively easy diagnostic to screen platelet granule abnormalities.
Maintenance of tumor vasculature integrity is indispensable for tumor growth and thus affects tumor progression. Previous studies have identified platelets as major regulators of tumor vascular integrity, as their depletion selectively renders tumor vessels highly permeable, causing massive intratumoral hemorrhage. While these results establish platelets as potential targets for anti-tumor therapy, depletion is not a treatment option due to the essential role of platelets for hemostasis. This thesis demonstrates for the first time that functional inhibition of glycoprotein (GP) VI on the platelet surface rapidly induces tumor hemorrhage and diminishes tumor growth similar to complete platelet depletion but without inducing systemic bleeding complications. Both, the intratumoral bleeding and tumor growth arrest could be reverted by depletion of Ly6G+ cells confirming them to be responsible for the induction of bleeding and necrosis within the tumor. In addition, GPVI inhibition increased intra-tumoral accumulation of co-administered chemotherapeutic agents, thereby resulting in a profound anti-tumor effect. In summary, this thesis manifests platelet GPVI as a key regulator of vascular integrity specifically in growing tumors, serving as a potential basis for the development of anti-tumor strategies.
In the second part of this thesis, light is shed on the modulating role of bridging integrator 2 (BIN2) in platelet Ca2+ signaling. Stromal interaction molecule 1 (STIM1) mediated store-operated calcium entry (SOCE) is the major route of Ca2+ influx in platelets, triggered by inositol trisphosphate receptor (IP3R)-dependent Ca2+ store release. In this thesis, the BAR domain superfamily member BIN2 was identified as the first Ca2+ signaling modulator, interacting with both, STIM1 and IP3R in platelets. Deletion of BIN2 resulted in reduced Ca2+ store release and Ca2+ influx in response to all tested platelet agonists. These defects were a consequence of impaired IP3R function in combination with defective STIM1-mediated SOC channel activation, while Ca2+ store content and agonist-induced IP3 production were unaltered. These results establish BIN2 as a central regulator of platelet Ca2+ signaling.
The third part of this thesis focuses on the effect of the soluble neuronal guidance protein Sema7A on platelet function. Rosenberger et al. discovered that Sema7A cleavage from red blood cells increases the formation of platelet-neutrophil complexes, thereby reinforcing thrombo-inflammation in myocardial ischemia-reperfusion injury (MIRI). This thesis establishes soluble Sema7A as a stimulator of platelet thrombus formation via its interaction with platelet GPIbα, thereby reinforcing PNC formation. Thus, interfering with the GPIb-Sema7A interaction during MIRI represents a potential strategy to reduce cardiac damage and improve clinical outcome following MI.
Knowing then defeating: The Ubiquitin activating enzyme, a promising target for cancer therapy
(2020)
Ubiquitin is a 76 amino acid long polypeptide, which is present throughout eukaryotes in a highly conserved fashion. Ubiquitin can modify proteins by becoming covalently attached to them. Eukaryotic cells employ ubiquitin to maintain and regulate fundamental cellular processes like protein degradation, the immune response and transcriptional and translational regulation. Transfer of ubiquitin to the substrate is achieved by the catalysis of three classes of enzymes namely E1, E2 and E3. Together these enzymes form a pyramidal hierarchy, where E1 stands at the apex and E3 enzymes form the base of the pathway.
The ubiquitin activating enzyme 1 (UBA1) plays a major role in ubiquitylation being the ubiquitin-dedicated E1 enzyme. In addition, it is the only enzyme in this pathway to use ATP as an energy source to catalyze two important reactions. The products of these reactions, ubiquitin adenylate and ubiquitin thioester, are the essential intermediate states of ubiquitin, for being conjugated to the target protein. With the help of X-ray crystallography and biochemical approaches, snapshots of multiple catalytic states of UBA1, where it is bound to Mg-ATP, ubiquitin and the E2 Ubc13 as substrates could be captured. With the help of these high-resolution crystal structures, deeper insights into the enzymatic mechanism of UBA1 could be attained. The resulting insights into the catalytic cycle were further validated by biochemical assays. It could be shown that ATP acts as a molecular switch to induce the enzyme’s open conformation. Ubiquitin-binding to the enzyme leads to domain rotations, which facilitate the recruitment of a cognate E2 enzyme. The interdomain communication as well as the cross-talk with the substrates and the products fuel the enzymatic cycle of UBA1.
Due to the proven efficacy of proteasome inhibitors for cancer treatment, which block degradation of proteins labeled with ubiquitin, enzymes participating in the ubiquitylation cascade have been targeted by researchers for the development of novel anti-cancer therapeutics. UBA1 inhibition has been shown to preferentially induce cell death in malignant cells, and it can also be used as a strategy to overcome resistance against proteasome inhibitors. MLN7243, an adenosyl sulfamate inhibitor developed by Millenium Pharmaceutical to specifically target UBA1, is currently in Phase-I clinical trials for the treatment of solid tumors. UBA1 could be crystallized in complex with three adenosyl sulfamate inhibitors covalently linked to ubiquitin, which are promising drug candidates for cancer therapy. The inhibitors employed, MLN7243, MLN4924 and ABPA3, show distinct specificities towards different E1 enzymes. With the help of crystal structures the specificity determinants of these inhibitors could be deciphered, which were further confirmed by inhibition assays as well as molecular dynamics simulations. Together these crystal structures provide a starting point for developing E1-specific inhibitors, which, besides their potential for medicinal purposes, are important tools to better understand the function of the ubiquitin system as well as the action of ubiquitin-like proteins.
The CXC chemokine receptor 4 (CXCR4) and the atypical chemokine receptor 3 (ACKR3) are seven transmembrane receptors that are involved in numerous pathologies, including several types of cancers. Both receptors bind the same chemokine, CXCL12, leading to significantly different outcomes. While CXCR4 activation generally leads to canonical GPCR signaling, involving Gi proteins and β‐arrestins, ACKR3, which is predominantly found in intracellular vesicles, has been shown to signal via β‐arrestin‐dependent signaling pathways. Understanding the dynamics and kinetics of their activation in response to their ligands is of importance to understand how signaling proceeds via these two receptors.
In this thesis, different Förster resonance energy transfer (FRET)‐based approaches have been combined to individually investigate the early events of their signaling cascades. In order to investigate receptor activation, intramolecular FRET sensors for CXCR4 and ACKR3 were developed by using the pair of fluorophores cyan fluorescence protein and fluorescence arsenical hairpin binder. The sensors, which exhibited similar functional properties to their wild‐type counterparts, allowed to monitor their ligand-induced conformational changes and represent the first RET‐based receptor sensors in the field of chemokine receptors. Additional FRET‐based settings were also established to investigate the coupling of receptors with G proteins, rearrangements within dimers, as well as G protein activation. On one hand, CXCR4 showed a complex activation mechanism in response to CXCL12 that involved rearrangements in the transmembrane domain of the receptor followed by rearrangements between the receptor and the G protein as well as rearrangements between CXCR4 protomers, suggesting a role of homodimers in the activation course of this receptor. This was followed by a prolonged activation of Gi proteins, but not Gq activation, via the axis CXCL12/CXCR4. In contrast, the structural rearrangements at each step of the signaling cascade in response to macrophage migration inhibitory factor (MIF) were dynamically and kinetically different and no Gi protein activation via this axis was detected. These findings suggest distinct mechanisms of action of CXCL12 and MIF on CXCR4 and provide evidence for a new type of sequential signaling events of a GPCR. Importantly, evidence in this work revealed that CXCR4 exhibits some degree of constitutive activity, a potentially important feature for drug development. On the other hand, by cotransfecting the ACKR3 sensor with K44A dynamin, it was possible to increase its presence in the plasma membrane and measure the ligand‐induced activation of this receptor. Different kinetics of ACKR3 activation were observed in response to CXCL12 and three other agonists by means of using the receptor sensor developed in this thesis, showing that it is a valuable tool to study the activation of this atypical receptor and pharmacologically characterize ligands. No CXCL12‐induced G protein activation via ACKR3 was observed even when the receptor was re-localized to the plasma membrane by means of using the mutant dynamin. Altogether, this thesis work provides the temporal resolution of signaling patterns of two chemokine receptors for the first time as well as valuable tools that can be applied to characterize their activation in response to pharmacologically relevant ligands.
Potential evolutionary responses to landscape heterogeneity and systematic environmental trends
(2020)
Over the course of the last century, humans have witnessed drastic levels of global environmental change that endangered both, the survival of single species as well as biodiversity itself. This includes climate change, in both environmental means and in variance and subsequently frequent extreme weather events, as well as land use change that species have to cope with.
With increasing urbanization, increasing agricultural area and increasing intensification, natural habitat is not only lost, but also changes its shape and distribution in the landscape. Both aspects can heavily influence an individual's fitness and therefore act as a selective force promoting evolutionary change.
This way climate change influences individuals' niches and dispersal. Local adaptation and dispersal are not independent of each other. Dispersal can have two opposite effects on local adaptation. It can oppose local adaptation, by promoting the immigration of maladapted indi-
viduals or favor local adaptation by introducing better adapted genotypes. Which of those effects of dispersal on local adaptation emerges in a population depends on the dispersal strategies and the spatial structure of the landscape. In principle an adaptive response can include adjustment of the niche optimum as well as habitat tolerance (niche width) or (instead) ecological tracking of adequate conditions by dispersal and range shifting. So
far, there has been no extensive modeling study of the evolution of the environmental niche optimum and tolerance along with dispersal probability in complex landscapes. Either only dispersal or (part of ) the environmental niche can evolve or the landscapes used are not realistic but rather a very abstract representation of spatial structures.
I want to try and disentangle those different effects of both local adaptation and dispersal during global change, as well as their interaction, especially considering the separation between the effects of increasing mean and increasing variance. For this, I implemented an individual based model (IBM), with escalating complexity.
I showed that both on a temporal as well as on a spatial scale, variation can be more influential then mean conditions.
Indeed, the actual spatial configuration of this heterogeneity and the relationship between spatial and temporal heterogeneity affect the evolution of the niche and of dispersal probability more than temporal or spatial mean conditions. I could show that in isolated populations, an increase of an environmental attribute's mean or variance can lead to extinction, under certain conditions. In particular, increasing variance cannot be tracked forever, since increasing tolerance has distinct limits of feasibility. Increasing mean conditions can also occur too fast to be tracked, especially from generalist individuals. When expanding the model to the metapopulation level without a temporal environmental trend, the degree of spatial vs.temporal heterogeneity influenced the evolution of random dispersal heavily. With increasing spatial heterogeneity, individuals from extreme and rare patches
evolve from being philopatric to dispersive, while individuals from average patches switch in the opposite direction.
With the last expansion to a different set of landscapes with varying degrees of edge density, I could show that edge effects are strong in pseudo-agricultural landscapes, while
in pseudo-natural habitats they were hardly found, regardless of emigration strategy. Sharp edges select against dispersal in the edge patches and could potentially further isolate populations in agricultural landscapes.
The work I present here can also be expanded further and I present several suggestions on what to do next. These expansions could help the realism of the model and eventually shed light on its bearing on ecological global change predictions. For example species distribution models or extinction risk models would be more precise, if they included both spatial and temporal variation. The current modeling practices might not be suffcient to
describe the possible outcomes of global change, because spatio-temporal heterogeneity and its influence on species' niches is too important to be ignored for longer.
Parkinson’s disease (PD) is among the most common neurodegenerative conditions, and it is characterized by the progressive loss of dopaminergic neurons and a great variability in clinical expression. Despite several effective medications, it still causes disability as all patients show treatment-resistant symptoms and complications.
A possible reason for this therapeutic-burden and great clinical variability lies in a probable misconception about its pathophysiology, one that focuses on neurodegeneration, while largely neglecting its functional consequences and the related compensatory changes. In this thesis, I expand on the hypothesis that some PD symptoms have a dysfunctional origin and reflect derangements of neural network dynamics, the means by which brain coordination supports any motor behaviour. In particular, I have investigated resting tremor and freezing of gait, two common symptoms with an enigmatic mechanism and suboptimal management.
In the case of tremor, I predicted a pathological change in response to dopamine loss, which included the activation of noradrenergic (NA) neurons of the locus coeruleus (LC) projecting to the cerebellum. This compensatory LC activation that supports dopaminergic neurons might indeed come at the expense of tremor development. To assess the role of LC-NA in tremor development, I recorded tremor occurrence in the reserpinized rat model of PD, one of very few showing tremor, after selective lesioning (with the neurotoxin DSP-4) of the LC-NA terminal axons. DSP-4 induced a severe reduction of LC-NA terminal axons in the cerebellar cortex and this was associated with a significant reduction in tremor development. Unlike its development, tremor frequency and the akinetic rigid signs did not differ between the groups, thus suggesting a dopaminergic dependency. These findings suggest that the LC-NA innervation of the cerebellum has a critical role for PD tremor, possibly by exerting a network effect, which gates the cerebello-thalamic-cortical circuit into pathological oscillations upon a dopaminergic loss in the basal ganglia.
In contrast, for the study of freezing of gait, I worked with human PD subjects and deep brain stimulation, a therapeutic neuromodulation device that in some prototypes also allows the recording of neural activity in freely-moving subjects. Gait freezing is a disabling PD symptom that suddenly impairs effective stepping, thus causing falls and disability. Also in this study, I hypothesized that the underlying pathophysiology may be represented by dysfunctional neural network dynamics that abruptly impair locomotor control by affecting the communication in the supraspinal locomotor network. To test this hypothesis, I investigated the coupling between the cortex and the subthalamic nucleus, two main nodes of the supraspinal locomotor network, in freely-moving subjects PD patients and also performed molecular brain imaging of striatal dopamine receptor density and kinematic measurements. I found that in PD patients, walking is associated with cortical-subthalamic stable coupling in a low-frequency band (i.e. θ-α rhythms). In contrast, these structures decoupled when gait freezing occurred in the brain hemisphere with less dopaminergic innervation. These findings suggest that freezing of gait is a “circuitopathy”, with dysfunctional cortical-subcortical communication.
Altogether the results of my experiments support the hypothesis that the pathophysiology of PD goes beyond neurodegenerative (loss-of-function) processes and that derangement of neural network dynamics coincides with some disabling PD symptoms, thus suggesting that PD can be interpreted as the combination of multiple circuitopathies.
TTFields sind eine Therapieoption des GBM, welche als alternierende elektrische Felder den Aufbau des mitotischen Spindelapparates stören. Gleichzeitig überwacht der SAC, mit seiner Schlüsselkomponente der Kinase MPS1, eine korrekte Anheftung der Spindelfasern an die Kinetochore der Chromosomen. Eine Inhibition des SAC durch den Inhibitor MPS1-IN-3 in Kombination mit Vincristin führt zu einem synergistischen Effekt auf das Tumorwachstum in vitro und in vivo. Aus diesen Erkenntnissen folgerten wir die Hypothese, dass eine SAC-Inhibition die Wirkung von TTFields verstärken könnte. Um dies zu testen, wurden Zellen der Zelllinien U87 und GaMG über 72h mit TTFields, MPS1-IN-3 oder einer Kombination aus den beiden behandelt. Anschließend wurden die Zellen gezählt, es wurde eine Analyse des Zellzyklus vorgenommen und apoptotische Zellen wurden via TUNEL-Assay detektiert. Die Kombinationsbehandlung aus TTFields und MPS1-IN-3 führte zu einer Reduktion der Zellzahl (U87: -54,3% vs. TTFields, p=0,0046; -52,9% vs. MPS1-IN-3, p=0,0026; GaMG: -74,3% vs. TTFields, p=0,0373; -84% vs. MPS1-IN-3, p<0,00001). Nur 28,1% mehr Zellen als ausgesät waren bei der Zelllinie U87 zu finden (TTFields: 179,1%; MPS1-IN-3: 168,3%), während es bei GaMG-Zellen sogar 62% weniger Zellen als ausgesät waren. Im Zellzyklus zeigte sich eine Abnahme der Zellen von der G1-Phase (U87: -59,9% vs. TTFields, p=0,0007; -42,1% vs. IN-3, p=0,0426; GaMG: -45,1% vs. TTFields, p=0,0276; -51,6% vs. IN-3, p=0,0020), während es zu einem massiven Anstieg von toten Zellen kam (U87: 2,9fach vs. TTFields, p=0,0022; 2,2fach vs. IN-3, p=0,0046; GaMG: 5,6fach vs. TTFields, p=0,0078; 7,8fach vs. IN-3, p=0,0005). Diese Zellen ließen sich im TUNEL-Assay als durch Apoptose zu Grunde gegangene Zellen weiter identifizieren (U87: 5,4fach vs. TTFields, p=0,0489; 6,2fach vs. IN-3, p=0,0278; GaMG: 8,9fach vs. IN-3, p=0,0110). Diese Ergebnisse sind erste und wichtige Hinweise für eine Verstärkung der Wirkung von TTFields durch eine Inhibition des SAC und liefern eine gute Grundlage für weitere Forschung zur Verbesserung der Therapie des GBM.
Despite the advancement in the treatment from genotoxic drugs to more targeted therapies, multiple myeloma (MM) remains incurable. MM is known for its complex genetic heterogeneity as different genetic lesion accrue over the course of the disease. The current work focuses on the functional analysis of genetic lesions found at the time of diagnosis and relapse and their potential role regarding therapy response and refractory disease. Genetic lesions involving tumor suppressor gene TP53, are found at diagnosis and tend to accrue during disease progression. Different types of mono- and biallelic TP53 alterations were emulated in the AMO1 cell line model, were functionally characterized and tested for their potential role in therapy response. Both types of single hit TP53 alteration (deletion 17p and TP53 point mutations) were found to have similar adverse effects on the functionality of the p53 system and response to genotoxic drugs which were completely abolished in the case of double hit TP53 alterations (no p53 expression, or mutant overexpression in wild type TP53 deletion background). Whereas, sensitivity to proteasome inhibitors remained unaltered. Using the clonal competition assay (CCA), single TP53 hit clones were found to have a fitness advantage over wildtype cells. Proliferative cell fitness was further enhanced in double hit TP53 clones, as they dominated wildtype and single hit TP53 clones in the CCA. Presence of external selection pressure in the form of low dose melphalan expedited the intrinsic fitness advantage. Alterations found in CUL4B, a component of CRL4-CRBN protein complex, a target of immunomodulatory drugs (IMiDs), were also functionally analyzed in the current study. Hotspot mutations and mutations found in IMiDs refractory patients were modelized in L363 cells and their role in IMiDs sensitivity was studied. CUL4B mutations were found not to be involved in providing lenalidomide resistance to the cell, whereas knocking CUL4B out was observed to provide negative fitness to the cells in CCA. In the presence of external selection pressure, these clones showed fitness, which was lost in the case of lenalidomide withdrawal. This shows that some alterations may play a role in refractory patients only in the presence of therapy, and as soon as therapy is discontinued, these altered clones may disappear such as clones with alterations in CUL4B. On the other hand, some alterations provide drug-independent intrinsic positive fitness, however, be further enhanced by drug exposure, such as seen in case of TP53 altered clones. Therefore, close monitoring and functional analysis of evolving clones is desired during disease progression, as it can be helpful in therapeutic guidance to achieve a better outcome for patients.
Background: Integrase strand transfer inhibitors (INSTIs) are the latest addition to the array of antiretroviral compounds used to treat an infection with Human Immunodeficiency Virus (HIV). Due to their high efficacy and increased tolerability, INSTIs have become an integral part of first-line therapy in most high-income countries over the past years. However, little is known about HIV-1’s genetic inter- and intra-subtype diversity on the Integrase (IN)-gene and its impact on the emergence of INSTI-resistance. In the absence of a functional cure, long-term efficacy of first-line compounds remains paramount for reducing virological failure and curbing on-going HIV transmissions. South Africa, harbouring more than 20% of the global HIV burden (7.7 / 37.9 million people), requires international attention in order to globally pursue UNAIDS’ (Joint United Nations Programme on HIV/AIDS) 90-90-90 goals and the road to ending the HIV/AIDS (Acquired immunodeficiency syndrome) pandemic by 2030.
Methods: In this study, the prevalence of INSTI-resistance associated mutations (RAM) was investigated in a cohort of 169 archived drug-naïve blood samples from multiple collection sites around Cape Town, South Africa. Viral RNA was isolated from plasma samples, the integrase fragment amplified by RT-PCR and subsequently sequenced by Sanger-sequencing. Additionally, all publicly available drug-naïve, South African IN sequences, isolated before the availability of the first INSTIs in 2007, were retrieved from the Los Alamos HIV sequence database (n=284). All sequences were analysed for RAMs using the Stanford HIV Drug resistance database. The identification of polymorphism in the South African subtype C IN consensus sequence allowed for comparative analyses with global subtype B, as well as subtype C sequences, from countries other than South Africa.
Results: The IN gene could be amplified and sequenced in 95/169 samples (56%). Phylogenetic inference revealed close homology between three sequence-pairs, warranting the exclusion of 3/95 sequences from further analyses. Of the 92 samples used for mutational analyses, 86/92 (93.5%) belonged to subtype C, 5/92 (5.4%) to subtype B and 1/92 (1.1%) to subtype A. The prevalence of major and accessory INSTI RAMs was 0/92 (0%) and 1/91 (1.1%), respectively, similar to the observed rates of 8/284 (2.8%) and 8/284 (2.8%) in the database sequences (p = 0.2076 and p = 0.6944, Fisher’s exact test). Compared to subtype B IN sequences, 15 polymorphisms were significantly enriched in South African subtype C sequences (corrected p<0.0015. Fisher’s exact test, Bonferroni post-hoc procedure).
Compared to subtype C IN sequences isolated outside South Africa, four polymorphisms were significantly enriched in this study cohort (corrected p<0.0014, Fisher’s exact test, Bonferroni post-hoc procedure). The highest prevalence margin was observed for the polymorphism Met50Ile being present in 60.1% of South African subtype C sequences, compared to 37% in non-South African subtype C sequences.
Conclusions: The low prevalence of major and minor RAMs in all South African Integrase sequences predicts a high susceptibility to INSTIs, however, the presence of natural polymorphisms, in particular Met50Ile, in the majority of sequences warrants further monitoring under therapeutic pressure, as their role in mutational pathways leading to INSTI- resistance is yet to be determined. Additionally, this study revealed the presence of substantial inter- and intra-subtype diversity within the HIV-1 Subtype C IN-gene. These results implicate the need for more research on a regional, potentially patient-specific level, as mutational insights from other diverse backgrounds may not accurately represent the South African context. The implementation of a national pre-treatment INSTI-resistance screening program may provide necessary insights into the development of mutational pathways leading to INSTI-resistance under therapeutic pressure for the South African context and thereby bring South Africa one step closer to achieving UNAIDS 90-90-90 goals and ending the AIDS epidemic by 2030.
The human body is laden with trillions of microorganisms that belong to all three domains of life. Some species of this microbiota subsist as harmless commensals in healthy adults, but under certain circumstances, they can cause mucosal disease or even systemic, life-threatening infections. While the bacterial members of our microbiota are heavily studied today, much less attention is afforded to eukaryotic species that colonize different mucocutaneous surfaces of the human body. This dissertation focuses on identifying regulatory circuits that enable a prominent member of these eukaryotes, C. albicans, to, on the one hand, live on a specific mammalian mucosal surface as a harmless commensal and, on the other hand, proliferate as a pathogen. Since the ultimate source of many fatal Candida infections is the gastrointestinal (GI) tract of the infected individual, this organism is particularly suited to distinguishing traits essential for the gut colonization of commensal fungi and their ability to cause disease. Sequence-specific DNA-binding proteins that regulate transcription are important to most biological processes; I thus used these proteins as starting points to gain insights into 1) how a specific transcription regulator promotes virulence in C. albicans; 2) which traits C. albicans requires to inhabit the GI tract of a specific, well-defined mouse model as a harmless commensal; and 3) how three previously undescribed transcriptional regulators contribute to the commensal colonization of the digestive tract of this mouse model. Altogether, this work advances the knowledge concerning the biology of commensal fungi in the mammalian gut and genetic determinants of fungal commensalism, as well as pathogenicity.
T cells play an essential role in the immune system. Engaging the T cell receptor (TCR) initiates a cascade of signaling events that activates the T cells. Neutral sphingomyelinase (NSM) is a member of a superfamily of enzymes responsible for the hydrolysis of sphingomyelin into phosphocholine and ceramide. Sphingolipids are essential mediators in signaling cascades involved in apoptosis, proliferation, stress responses, necrosis, inflammation, autophagy, senescence, and differentiation.
Upon specific ablation of NSM2, T cells proved to be hyper-responsive to CD3/CD28 co-stimulation, indicating that the enzyme acts to dampen early overshooting activation of these cells. It remained unclear whether a deregulated metabolic activity supports the hyper-reactivity of NSM2 deficient T cells. This work demonstrates that the ablation of NSM2 activity affects the metabolism of the quiescent CD4+ T cells. These accumulate ATP in mitochondria and increase basal glycolytic activity by increasing the basal glucose uptake and GLUT1 receptor expression, which, altogether, raises intracellular ATP levels and boosts cellular respiration. The increased basal metabolic activity is associated with rapid phosphorylation of S6, a mTORC1 target, as well as enhanced elevation total ATP levels within the first hour after CD3/CD28 costimulation. Increased metabolic activity in resting NSM2 deficient T cells does, however, not support sustained stimulated responses. While elevated under steady-state conditions and elevated early after co-stimulation in NSM2 deficient CD4+ T cells, the mTORC1 pathway regulating mitochondria size, oxidative phosphorylation, and ATP production is impaired after 24 hours of stimulation. Taken together, the absence of NSM2 promotes a hyperactive metabolic state in unstimulated CD4+ T cells yet fails to support sustained T cell responses upon antigenic stimulation without affecting T cell survival.
Serotonin (5-hydroxytryptamine, 5-HT) is a neurotransmitter involved in early
developmental processes such as cell proliferation, migration, and differentiation.
Recent research in humans showed that the brain 5-HT system and CDH13 are
interlinked in the genetics of neurodevelopmental disorders including attention-
deficit/hyperactivity disorder and autism spectrum disorder (Lesch et al., 2008;
Neale et al., 2008; Neale, Medland, Ripke, Anney, et al., 2010; Neale, Medland,
Ripke, Asherson, et al., 2010; Sanders et al., 2011; Sanders et al., 2015; Zhou et
al., 2008). This study introduces Cadherin-13 (CDH13), a cell adhesion protein, as
a contributor to the development and function of the 5-HT system. Our
experiments show that the absence of CDH13 increases the density of 5-HT
neurons in the developing dorsal raphe (DR) and increases the 5-HT innervation
of the prefrontal cortex in mouse embryonic stages. CDH13 is also observed in
radial glial cells, an important progenitor cell type linked to neuronal migration.
A three-dimensional reconstruction carried out with super-resolution microscopy,
identifies 5-HT neurons intertwined with radial glial cells, and CDH13 clusters at
contact points between these cells. This indicates a potential contribution of
CDH13 to the migration of DR 5-HT neurons. As CDH13 is strongly expressed in
5-HT neurons, we asked whether the selective deletion of CDH13 from these cells
is sufficient to generate the alterations observed in the Cdh13 constitutive
knockout mouse line.
In 5-HT conditional Cdh13 knockout mice (Cdh13 cKO) an increase in DR 5-HT
neurons in the embryonic and adult brains is observed, as well as 5-HT
hyperinnervation of cortical regions. Therefore, illustrating that the lack of CDH13
from 5-HT neurons alone impacts DR formation and serotonergic innervation.
Behavioral testing conducted on Cdh13 cKO mice showed delayed learning in
visuospatial learning and memory processing, as well as, changes in sociability
parameters. To find out how CDH13 localizes in human 5-HT neurons, CDH13 was
visualized in neurons that derived from human induced pluripotent stem cells
(iPSC). Super-resolution microscopy confirmed CDH13 expression in a subgroup
of induced human neurons positive for typical hallmarks of 5-HT neurons, such as
expression of Tph2, the neuron-specific tryptophan hydroxylase, and synaptic
structures. In summary, the work included in this thesis presents a detailed
analysis of CDH13 expression and localization in the 5-HT system and shows that
deletion of CDH13 from 5-HT neurons affects specific higher-order functions of the
brain.
Induced pluripotent stem cells (iPSCs) have been recognised as a virtually unlimited source of stem cells that can be generated in a patient-specific manner. Due to these cells’ potential to give rise to all differentiated cell types of the human body, they have been widely used to derive differentiated cells for drug screening and disease modelling purposes. iPSCs also garner much interest as they can potentially serve as a source for cell replacement therapy. Towards the realisation of these biomedical applications, this thesis aims to address challenges that are associated with scale-up, safety and biofabrication.
Firstly, the manufacture of a high number of human iPSCs (hiPSCs) will require standardised procedures for scale-up and the development of a flexible bioprocessing method, since standard adherent hiPSC culture exhibits limited scalability and is labour-intensive. While the quantity of cells that are required for cell therapy depends largely on the tissue and defect that these replacing cells are meant to correct, an estimate of 1 × 10^9 has been suggested to be sufficient for several indications, including myocardial infarction and islet replacement for diabetes. Here, the development of an integrated, microcarrier-free workflow to transition standard adherent hiPSC culture (6-well plates) to scalable stirred suspension culture in bioreactors (1 L working volume, 2.4 L maximum working volume) is presented. The two-phase bioprocess lasts 14 days and generates hiPSC aggregates measuring 198 ± 58 μm in diameter on the harvesting day, yielding close to 2 × 10^9 cells. hiPSCs can be maintained in stirred suspension for at least 7 weeks with weekly passaging, while exhibiting pluripotency-associated markers TRA-1-60, TRA-1-81, SSEA-4, OCT4, and SOX2. These cells retain their ability to differentiate into cells of all the three germ layers in vitro, exemplified by cells positive for AFP, SMA, or TUBB3. Additionally, they maintain a stable karyotype and continue to respond to specification cues, demonstrated by directed differentiation into beating cardiomyocyte-like cells. Therefore, the aim of manufacturing high hiPSC quantities was met using a state-of-the-art scalable suspension bioreactor platform.
Secondly, multipotent stem cells such as induced neural stem cells (iNSCs) may represent a safer source of renewable cells compared to pluripotent stem cells. However, pre-conditioning of stem cells prior to transplantation is a delicate issue to ensure not only proper function in the host but also safety. Here, iNSCs which are normally maintained in the presence of factors such as hLIF, CHIR99021, and SB431542 were cultured in basal medium for distinct periods of time. This wash-out procedure results in lower proliferation while maintaining key neural stem cell marker PAX6, suggesting a transient pre-differentiated state. Such pre-treatment may aid transplantation studies to suppress tumourigenesis through transplanted cells, an approach that is being evaluated using a mouse model of experimental focal demyelination and autoimmune encephalomyelitis.
Thirdly, biomedical applications of stem cells can benefit from recent advancements in biofabrication, where cells can be arranged in customisable topographical layouts. Employing a 3DDiscovery bioprinter, a bioink consisting of hiPSCs in gelatin-alginate was extruded into disc-shaped moulds or printed in a cross-hatch infill pattern and cross-linked with calcium ions. In both discs and printed patterns, hiPSCs recovered from these bioprints showed viability of around 70% even after 4 days of culture when loaded into gelatin-alginate solution in aggregate form. They maintained pluripotency-associated markers TRA-1-60 and SSEA-4 and continued to proliferate after re-plating. As further proof-of-principle, printed hiPSC 3D constructs were subjected to targeted neuronal differentiation, developing typical neurite outgrowth and resulting in a widespread network of cells throughout and within the topology of the printed matrix. Staining against TUBB3 confirmed neuronal identity of the differentiated cellular progeny. In conclusion, these data demonstrate that hiPSCs not only survive the 3D-printing process but were able to differentiate along the printed topology in cellular networks.
The role of the adhesion and degranulation promoting adapter protein (ADAP) in platelet production
(2020)
Bone marrow (BM) megakaryocytes (MKs) produce platelets by extending proplatelets into sinusoidal blood vessels. Although this process is fundamental to maintain normal platelet counts in circulation only little is known about the regulation of directed proplatelet formation.
As revealed in this thesis, ADAP (adhesion and degranulation promoting adapter protein) deficiency (constitutive as well as MK and platelet-specific) resulted in a microthrombocytopenia in mice, recapitulating the clinical hallmark of patients with mutations in the ADAP gene. The thrombocytopenia was caused by a combination of an enhanced removal of platelets from the circulation by macrophages and a platelet production defect. This defect led to an ectopic release of (pro)platelet-like particles into the bone marrow compartment, with a massive accumulation of such fragments around sinusoids. In vitro studies of cultured BM cell-derived MKs revealed a polarization defect of the demarcation membrane system, which is dependent on F-actin dynamics. ADAP-deficient MKs spread on collagen and fibronectin displayed a reduced F-actin content and podosome density in the lowest confocal plane. In addition, ADAP-deficient MKs exhibited a reduced capacity to adhere on Horm collagen and in line with that the activation of beta1-integrins in the lowest confocal plane of spread MKs was diminished. These results point to ADAP as a novel regulator of terminal platelet formation.
Beside ADAP-deficient mice, three other knockout mouse models (deficiency for profilin1 (PFN1), Wiskott-Aldrich-syndrome protein (WASP) and Actin-related protein 2/3 complex subunit 2 (ARPC2)) exist, which display ectopic release of (pro)platelet-like particles. As shown in the final part of the thesis, the pattern of the ectopic release of (pro)platelet-like particles in these genetically modified mice (PFN1 and WASP) was comparable to ADAP-deficient mice. Furthermore, all tested mutant MKs displayed an adhesion defect as well as a reduced podosome density on Horm collagen. These results indicate that similar mechanisms might apply for ectopic release.